Board Members
Jamie Gibson joined Compedica in 2020 and was appointed as a non-executive director and chairman of the company from 7 April 2021. Mr Gibson holds an approx 8% interest in the Company.
Mr Gibson has spent most of his professional career specialising in corporate finance, direct equity investments and structuring emerging market investment products. Since 1996, Mr Gibson has held leadership positions at Endurance RP (“Endurance”) and in May 2002, he became Chief Executive Officer. Endurance is a Hong Kong-based investment company holding ground-breaking corporate and strategic investments focused on the healthcare and life sciences sectors. Mr Gibson holds a law degree from Edinburgh University.
James Mellon (alias: Jim Mellon), is the Founder and Executive Director of Compedica. Mr Mellon has spent his entire career in asset management and he specialises in the development and restructuring of international investment vehicles. Mr Mellon holds an approx 47% interest in the Company.
In 1990, Mr Mellon co-founded and became Chief Executive of Regent Pacific Group (now known as Endurance RP Limited) (“Endurance”). The Hong Kong-based investment company has emerged as a worldwide leader in ground-breaking corporate and strategic investments focused on the healthcare and life sciences sectors. In 1994, he became Endurance’s Chairman and director of certain of its subsidiaries: (i) the non-executive director of Agronomics Limited (having stepped down as the chairman of its board on 31 May 2019 and remaining as a non-executive director), a non-executive director of Condor Gold plc and the executive chairman of the board of Manx Financial Group plc, all of which are listed on the London Stock Exchange AIM (“AIM”) ; (ii) a non-executive director of Bradda Head Holdings Limited (which was de-listed from AIM on 6 October 2017 and readmitted to trading as of 19 July 2021); and (iii) the non-executive chairman of the board of Speymill Deutsche Immobilien Company plc (which was de-listed from AIM on 31 May 2011). Mr. Mellon is currently Endurance’s Non-Executive Chairman of the Board of Directors.
Mr Mellon holds a Master’s degree in Politics, Philosophy and Economics from Oxford University.
Denham Eke is a Director of Compedica. Mr Eke has extensive experience in finance, especially as it relates to rationalising and restructuring operations to enhance profitability. He has held directorships of a large number of companies, principally involved in the finance, mining, property and leisure sectors, including Chairman of Webis plc; CEO of Manx Financial Group plc and Speymill plc; CFO of Emerging Metals plc and Copper Development Corporation; and a director of ARBB AG.
Currently he is the Managing Director of the Burnbrae Group which seeks out opportunistic investments and capitalises on fundamental global emerging trends.
Executive Team
Daniel Blackman joined Compedica in 2016 and in 2020, was appointed as the Chief Operating Officer and Medical Director of the company.
Mr Blackman is consultant podiatrist and a specialist in biomechanics and lower limb rehabilitation, having spent 14 years in the NHS, Elite sport and MOD as a speciality lead. He has extensive experience in commercial healthcare related to medical device innovation and product development. Prior to Compedica, he held snr leadership positions at medical technology, orthotics and clinical services companies.
Mr Blackman is a graduate of Birmingham School of Podiatry, and remains a member of the Royal College of Podiatry.
Michael Holvey began his affiliation with Compedica in 2015 as Chief Financial Officer. He has extensive background in financial management of international Medical Device, Consumer Goods and Metal Manufacturing industries.
Mr Holvey Leadership strengths include business start-up and transformation projects, business performance management, finance processes, financial reporting and strategic decision making.
Mr Holvey holds a degree in accountancy from the Bath Technical School.
Patrice Laterra McMorrow joined Compedica in 2018 as a Vice President focused on marketing and operations in the Unites States.
Ms McMorrow has over 25 years of consulting experience in start-up medical device, manufacturing, and defense-sector companies, as well as fully commercialized pharmaceutical corporations. She is accustomed to entrepreneurial business environments and leading multifunctional teams of internal and external personnel to drive business initiatives, sales operations and market introductions of products and services.
Ms McMorrow holds a Master of Business Administration from Seton Hall University’s Stillman School of Business.
